SK280845B6 - Kyselina erytro-(e)-3,5-dihydroxy-7-[3'-(4''-fluórfenyl)-1'- -(1''-metyletyl)indol-2'-yl]-hept-6-énová a spôsob jej výroby - Google Patents

Kyselina erytro-(e)-3,5-dihydroxy-7-[3'-(4''-fluórfenyl)-1'- -(1''-metyletyl)indol-2'-yl]-hept-6-énová a spôsob jej výroby Download PDF

Info

Publication number
SK280845B6
SK280845B6 SK5797-89A SK579789A SK280845B6 SK 280845 B6 SK280845 B6 SK 280845B6 SK 579789 A SK579789 A SK 579789A SK 280845 B6 SK280845 B6 SK 280845B6
Authority
SK
Slovakia
Prior art keywords
formula
compound
ester
racemic
optically pure
Prior art date
Application number
SK5797-89A
Other languages
English (en)
Slovak (sk)
Other versions
SK579789A3 (en
Inventor
Kau-Ming Chen
Prasad Koteswara Kapa
George T. Lee
Oljan Repic
Petr Hess
Michel Crevoisier
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26945992&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK280845(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of SK579789A3 publication Critical patent/SK579789A3/sk
Publication of SK280845B6 publication Critical patent/SK280845B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C223/00—Compounds containing amino and —CHO groups bound to the same carbon skeleton
    • C07C223/02—Compounds containing amino and —CHO groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
SK5797-89A 1988-10-13 1989-10-12 Kyselina erytro-(e)-3,5-dihydroxy-7-[3'-(4''-fluórfenyl)-1'- -(1''-metyletyl)indol-2'-yl]-hept-6-énová a spôsob jej výroby SK280845B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25747588A 1988-10-13 1988-10-13
US35553189A 1989-05-22 1989-05-22

Publications (2)

Publication Number Publication Date
SK579789A3 SK579789A3 (en) 2000-08-14
SK280845B6 true SK280845B6 (sk) 2000-08-14

Family

ID=26945992

Family Applications (1)

Application Number Title Priority Date Filing Date
SK5797-89A SK280845B6 (sk) 1988-10-13 1989-10-12 Kyselina erytro-(e)-3,5-dihydroxy-7-[3'-(4''-fluórfenyl)-1'- -(1''-metyletyl)indol-2'-yl]-hept-6-énová a spôsob jej výroby

Country Status (24)

Country Link
EP (2) EP0363934B1 (de)
JP (1) JP2853227B2 (de)
KR (1) KR0162656B1 (de)
AT (1) ATE99281T1 (de)
AU (1) AU636122B2 (de)
BG (1) BG60555B1 (de)
CA (1) CA2000553C (de)
CZ (1) CZ283316B6 (de)
DE (1) DE68911834T2 (de)
DK (1) DK175073B1 (de)
ES (1) ES2060712T3 (de)
FI (1) FI98063C (de)
HK (1) HK49496A (de)
HU (1) HU207993B (de)
IE (2) IE940109L (de)
IL (1) IL91941A (de)
MY (1) MY105067A (de)
NO (1) NO174623C (de)
NZ (1) NZ230973A (de)
RO (1) RO109732B1 (de)
SG (1) SG139553A1 (de)
SK (1) SK280845B6 (de)
WO (1) WO1990003962A1 (de)
YU (1) YU48466B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290946A (en) * 1988-10-13 1994-03-01 Sandoz Ltd. Processes for the synthesis of 3-(substituted indolyl-2-yl)propenaldehydes
US5118853A (en) * 1988-10-13 1992-06-02 Sandoz Ltd. Processes for the synthesis of 3-disubstituted aminoacroleins
JPH03184961A (ja) * 1989-10-10 1991-08-12 Glaxo Group Ltd 化合物
DE4424525A1 (de) * 1994-07-12 1995-01-26 Elmar Meyer Dauermagnet-Kolbenmotor
GT199800127A (es) 1997-08-29 2000-02-01 Combinaciones terapeuticas.
DK1216038T3 (da) 1999-08-30 2005-12-27 Sanofi Aventis Deutschland Anvendelse af inhibitorer af reninangiotensinsystemet ved forebyggelsen af cardiovaskulære hændelser
CN1217930C (zh) 2000-05-26 2005-09-07 西巴特殊化学品控股有限公司 吲哚衍生物的制备方法和该方法的中间体
US7777006B2 (en) 2002-12-31 2010-08-17 Csl Behring L.L.C. Method for purification of alpha-1-antitrypsin
EP1623976A4 (de) * 2003-04-24 2008-07-30 Daicel Chem Verfahren zur trennung optisch aktiver dihydroxyheptensäureester
US7368468B2 (en) 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Fluvastatin sodium crystal forms XIV, LXXIII, LXXIX, LXXX and LXXXVII, processes for preparing them, compositions containing them and methods of using them
US7368581B2 (en) 2003-06-18 2008-05-06 Teva Pharmaceutical Industries Ltd. Process for the preparation of fluvastatin sodium crystal from XIV
JP4037898B2 (ja) 2003-06-18 2008-01-23 テバ ファーマシューティカル インダストリーズ リミティド フルバスタチンナトリウム結晶形ｘｉｖ、ｌｘｘｉｉｉ、ｌｘｘｉｘ、ｌｘｘｘ及びｘｘｘｖｉｉ型、それらの調製方法、それらを含有する組成物及びそれらの使用方法
JP2007512347A (ja) 2003-11-26 2007-05-17 デューク・ユニバーシティー 緑内障を予防するかまたは治療する方法
US7851624B2 (en) 2003-12-24 2010-12-14 Teva Pharamaceutical Industries Ltd. Triol form of rosuvastatin and synthesis of rosuvastatin
US20060211752A1 (en) 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ATE431818T1 (de) 2006-04-20 2009-06-15 Italiana Sint Spa Verfahren zur herstellung von fluvastatin-natrium
EP2327682A1 (de) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Verwendung von amphiphilen Verbindungen zur gesteuerten Kristallisation von Statinen und Statin Zwischenprodukte.
EP2373609B1 (de) 2008-12-19 2013-10-16 KRKA, D.D., Novo Mesto Verwendung amphiphiler verbindungen zur kontrollierten kristallisation von statinen und statinzwischenprodukten
CN104902892A (zh) 2012-02-02 2015-09-09 悉尼大学 泪液膜稳定性的改进
EP2986599A1 (de) 2013-04-17 2016-02-24 Pfizer Inc. N-piperidin-3-ylbenzamid-derivate zur behandlung von herz-kreislauf-erkrankungen
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso
WO2025168652A1 (en) 2024-02-05 2025-08-14 Astrazeneca Ab Azd-0780 in combination with a statin for use in lowering ldl-c levels and treating cardiovacular diseases
TW202602886A (zh) 2024-03-20 2026-01-16 瑞典商阿斯特捷利康公司 Ｐｃｓｋ９抑制劑及其使用方法
TW202602866A (zh) 2024-03-20 2026-01-16 瑞典商阿斯特捷利康公司 Ｐｃｓｋ９抑制劑及其使用方法
TW202539678A (zh) 2024-03-20 2025-10-16 瑞典商阿斯特捷利康公司 Ｐｃｓｋ９抑制劑及其使用方法
WO2025238159A1 (en) 2024-05-16 2025-11-20 Astrazeneca Ab Combination therapy comprising azd0780 and ezetimibe

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB945536A (en) * 1961-09-08 1964-01-02 Istituto Chemioterapico Method of preparing ª -amino-acroleins
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
HU204253B (en) * 1982-11-22 1991-12-30 Sandoz Ag Process for producing mevalonolactone analogues and derivatives and pharmaceutical compositions containing them
US4571428A (en) * 1983-07-08 1986-02-18 Sandoz, Inc. 6-Substituted-4-hydroxy-tetrahydropyran-2-ones
US4650890A (en) * 1984-04-03 1987-03-17 Sandoz Corp. Preparation of olefinic compounds and intermediates thereof
ATE62906T1 (de) * 1984-06-22 1991-05-15 Sandoz Ag Pyrazolanaloge von mevalonolakton und abkoemmlinge davon, verfahren zu deren herstellung und deren verwendung.
ATE60571T1 (de) * 1984-12-04 1991-02-15 Sandoz Ag Inden-analoga von mevalonolakton und ihre derivate.
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
EP0244364A3 (de) * 1986-04-30 1992-04-01 Sandoz Ag Herstellung von olefinischen Verbindungen
NZ221717A (en) * 1986-09-10 1990-08-28 Sandoz Ltd Azaindole and indolizine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
IE63477B1 (en) 1995-04-19
KR0162656B1 (ko) 1999-01-15
ATE99281T1 (de) 1994-01-15
NO902598D0 (no) 1990-06-12
YU197389A (en) 1990-12-31
IL91941A (en) 1994-10-21
DK175073B1 (da) 2004-05-24
CZ579789A3 (en) 1997-11-12
JP2853227B2 (ja) 1999-02-03
HK49496A (en) 1996-03-29
EP0562643A2 (de) 1993-09-29
MY105067A (en) 1994-07-30
FI98063B (fi) 1996-12-31
KR900701723A (ko) 1990-12-04
JPH03501735A (ja) 1991-04-18
IL91941A0 (en) 1990-06-10
EP0363934A1 (de) 1990-04-18
NO174623C (no) 1994-06-08
NO174623B (no) 1994-02-28
HUT53860A (en) 1990-12-28
DK144690D0 (da) 1990-06-13
DE68911834D1 (de) 1994-02-10
DE68911834T2 (de) 1994-06-23
EP0363934B1 (de) 1993-12-29
SK579789A3 (en) 2000-08-14
CZ283316B6 (cs) 1998-02-18
HU896048D0 (en) 1990-11-28
EP0562643A3 (en) 1994-05-18
CA2000553C (en) 2001-12-04
IE940109L (en) 1990-04-13
AU4344889A (en) 1990-05-01
IE893277L (en) 1990-04-13
FI902935A0 (fi) 1990-06-12
RO109732B1 (ro) 1995-05-30
BG60555B1 (en) 1995-08-28
CA2000553A1 (en) 1990-04-13
ES2060712T3 (es) 1994-12-01
FI98063C (fi) 1997-04-10
NZ230973A (en) 1993-03-26
BG92179A (bg) 1993-12-24
AU636122B2 (en) 1993-04-22
DK144690A (da) 1990-06-13
YU48466B (sh) 1998-08-14
WO1990003962A1 (en) 1990-04-19
NO902598L (no) 1990-08-07
SG139553A1 (en) 2008-02-29
HU207993B (en) 1993-07-28

Similar Documents

Publication Publication Date Title
SK280845B6 (sk) Kyselina erytro-(e)-3,5-dihydroxy-7-[3'-(4''-fluórfenyl)-1'- -(1''-metyletyl)indol-2'-yl]-hept-6-énová a spôsob jej výroby
US5189164A (en) Processes for the synthesis of syn-(E)-3,5-dihydroxy-7-substituted hept-6-enoic and heptanoic acids and derivatives and intermediates thereof
EP0235164B1 (de) Mevalonolactonähnliche imidazole und derivate
TW201323391A (zh) 用於合成苯并茚前列腺素之中間物及其製備方法
CN1305853C (zh) Hmg辅酶a还原酶抑制剂的制备方法
PL163178B1 (pl) Sposób wytwarzania nowych pochodnych kwasu 1,3-dioksanoalkenowego PL PL PL
KR20040077883A (ko) 유기 화합물의 제조 방법
EA016650B1 (ru) Способ асимметрического алкилирования карбонильной группы
EP0367895A1 (de) Pyrimidinyl substituierte Hydroxysäuren, Laktone und Ester und diese enthaltende pharmazeutische Zusammenstellungen
US4851427A (en) Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
KR20020015068A (ko) 치환된 피페리딘-4-온의 제조 방법
CN113993849B (zh) 用于制备2-(2,6-二氯苯基)-1-[(1s,3r)-3-(羟甲基)-5-(3-羟基-3-甲基丁基)-1-甲基-3,4-二氢异喹啉-2(1h)-基]乙烯酮的方法和中间体
EP1478650B1 (de) Neue boronatester
US4870199A (en) Processes for the synthesis of diprotected R[R*,S*]-3,5-dihydroxy-6-oxohexanoate esters
US5693816A (en) Process for the preparation of diisopinocampheylchloroborane
JPS61129178A (ja) ＨＭＧ‐ＣｏＡ還元酵素阻害剤及びそれに使用する中間体化合物の製造方法
JP3303327B2 (ja) 不斉誘起触媒
RU2051907C1 (ru) Способ получения 7-замещенной гептен-6-овой кислоты
KR100850850B1 (ko) 아토르바스타틴의 제조방법 및 이에 사용되는 중간체
JP4540197B2 (ja) （ｅ）−３−メチル−２−シクロペンタデセノンの製造法
US5973161A (en) Enantioselective synthesis of cyclopentenes
US4973704A (en) Pyrrolyl intermediates in the synthesis of pyrrole analogs of mevalonolactone and derivatives thereof
JP2974181B2 (ja) シクロブタノールの新規な製造法
KR20120059148A (ko) 피타바스타틴의 제조를 위한 키랄 중간체의 제조방법
JP2002114749A (ja) 光学活性２−ヒドロキシ−３−フェニルプロピオニトリル誘導体の製造法